Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Rose Chang, ScD, MS, MSPH
Vice President
Analysis Group, Inc., Boston, MA
Poster(s):
(070) NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
(108) Impact of Treatment of COVID-19 with Sotrovimab on Post-Acute COVID-19 Syndrome: An Analysis of National COVID Cohort Collaborative (N3C) Data
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
